In urine samples, the prostate-specific antigen and prostatic acid phosphatase levels were significantly decreased, whereas neutrophil defensin 1 was significantly elevated in stage III and IV lung adenocarcinoma patients. Here, ACP3 is linked to lung adenocarcinoma.